Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trials begin of plaque-removing device:

This article was originally published in Clinica

Executive Summary

The first procedures using a new catheter-based device for removing plaque loosened during stenting of heart bypass patients have begun in the US. The PercuSurge device, made by the Sunnyvale, California company of the same name, consists of an angioplasty guidewire with a low-pressure occlusion balloon at its tip. The device has the European CE mark and the FDA has granted an investigational device exemption for a multicentre, randomised study of the device, called SAFER (saphenous vein grafts angioplasty free of embolism randomised study).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT082743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel